Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 1;207(9):1243-1246.
doi: 10.1164/rccm.202212-2203LE.

Ozone Reaction Products Associated with Biomarkers of Cardiorespiratory Pathophysiology

Affiliations

Ozone Reaction Products Associated with Biomarkers of Cardiorespiratory Pathophysiology

Linchen He et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The percent change in adverse effects (increase or decrease) associated with a 10-ppb increase in ozone (O3) exposure (controlled for particulate matter ⩽2.5 μm in aerodynamic diameter (PM2.5) and O3 loss exposure) and a 10-ppb increase in O3 loss exposure (controlled for PM2.5 and O3 exposure) in the Children study. Only biomarkers that show a statistically significant association (P value < 0.05) with 12-hour, 24-hour (at any of lag days), or 2-week average O3 or O3 loss exposure are shown. If multiple significant or nonsignificant associations were found, the associations with the smallest P value are shown in the figure. Significant and adverse associations between biomarkers and O3 loss exposures: FeNO (fractional exhaled nitric oxide) (12-h, 24-h, lag Day 2, 2-wk), Z5 (24-h), X5 (24-h), Fres (24-h, lag Day 1), FEV1/FVC: (12-h). A positive value (y-axis) indicates an adverse effect, and a negative value indicates a beneficial effect. Fixed-effect covariates: Sex, age, ambient temperature and humidity, baseline eosinophil number (/μl), upper airway tract infection-like symptoms (binary), inhaled corticosteroid usage (binary), asthma exacerbation (binary). A sensitivity analysis for FEV1/FVC: and FeNO by adjusting for height and weight showed similar results. Participant baseline characteristics: Age (mean [SD] = 7.8 [2.3], range = 5–13, and unit = years), sex (17 males and 26 females), eosinophil count (mean [SD] = 379 [265], range = 80–1260, and unit = /μl). CI = confidence interval; Fres = resonant frequency; MDA = malondialdehyde; X5 = reactance at 5 Hz; Z5 = impedance at 5 Hz.
Figure 2.
Figure 2.
The percent change in adverse effects (increase or decrease) associated with a 10-ppb increase in ozone (O3) exposure (controlled for particulate matter ⩽2.5 μm in aerodynamic diameter (PM2.5) and O3 loss exposure) and a 10-ppb increase in O3 loss exposure (controlled for PM2.5 and O3 exposure) in the Adults study. Only biomarkers that show a statistically significant association (P value < 0.05) with 12-hour, 24-hour (at any of lag days), or 2-week average O3 or O3 loss exposure are shown. If multiple significant or nonsignificant associations were found, the associations with the smallest P value are shown in the figure. Significant and adverse associations between biomarkers and O3 loss exposures: EBC NN (nitrate and nitrite in exhaled breath condensate) (12-h, lag Day 2), FeNO (fractional exhaled nitric oxide) (lag Day 1, lag Day 2, 2-wk), 8-OHdG (8-hydroxy-2′-deoxyguanosine) (12-h, lag Day 2), 20-HETE (12-h, lag Day 1, lag Day 2, 2-wk), P-selectin (12-h, lag Day 1, lag D 2), DBP (24-h, lag Day 1, lag Day 2, 2-wk), SBP (12-h, 24-h, lag Day 1, lag Day 2, 2-wk). A positive value (y-axis) indicates an adverse effect, and a negative value indicates a beneficial effect. Fixed-effect covariates: sex, age, ambient temperature and humidity, time since last eating (h), secondhand smoke exposure (h), current smoking status (binary), urinary 6-sulfatoxymelatonin (ng/ml, as a surrogate of circulating melatonin, is adjusted when EBC NN, EBC MDA, or 8-OHdG is the health outcome). A sensitivity analysis for FeNO by adjusting for height and weight showed similar results. Participant baseline characteristics: age (mean [SD] = 31.5 [7.6], range = 22–52, and unit = years), sex (64 males and 25 females), current smoker (n = 15). 20-HETE = 20-hydroxyeicosatetraenoic acid; AI = augmentation index; CI = confidence interval; DBP = diastolic blood pressure; MDA = malondialdehyde; PWV = pulse wave velocity; SBP= systolic blood pressure; VWF = von Willebrand factor.

Similar articles

Cited by

References

    1. Murray CJ, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. GBD 2019 Risk Factors Collaborators Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet . 2020;396:1223–1249. - PMC - PubMed
    1. Weschler CJ. Ozone’s impact on public health: contributions from indoor exposures to ozone and products of ozone-initiated chemistry. Environ Health Perspect . 2006;114:1489–1496. - PMC - PubMed
    1. Liu Y, Misztal PK, Arata C, Weschler CJ, Nazaroff WW, Goldstein AH. Observing ozone chemistry in an occupied residence. Proc Natl Acad Sci USA . 2021;118:e2018140118. - PMC - PubMed
    1. Fiedler N, Laumbach R, Kelly-McNeil K, Lioy P, Fan Z-H, Zhang J, et al. Health effects of a mixture of indoor air volatile organics, their ozone oxidation products, and stress. Environ Health Perspect . 2005;113:1542–1548. - PMC - PubMed
    1. Laumbach RJ, Fiedler N, Gardner CR, Laskin DL, Fan Z-H, Zhang J, et al. Nasal effects of a mixture of volatile organic compounds and their ozone oxidation products. J Occup Environ Med . 2005;47:1182–1189. - PubMed

Publication types